AMPEC4: <i>Naja ashei</i> Venom-Derived Peptide as a Stimulator of Fibroblast Migration with Antibacterial Activity

The treatment of proctological conditions, including hemorrhoids, anal fissures, and perianal abscesses, is often complicated by bacterial infections, particularly those involving multidrug-resistant <i>Escherichia coli</i>. This study presents the synthesis, characterization, and biolog...

Full description

Saved in:
Bibliographic Details
Main Authors: Ewa Ciszkowicz, Anna Miłoś, Andrzej Łyskowski, Justyna Buczkowicz, Anna Nieczaj, Katarzyna Lecka-Szlachta, Konrad K. Hus, Karol Sikora, Damian Neubauer, Marta Bauer, Wojciech Kamysz, Aleksandra Bocian
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/30/10/2167
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The treatment of proctological conditions, including hemorrhoids, anal fissures, and perianal abscesses, is often complicated by bacterial infections, particularly those involving multidrug-resistant <i>Escherichia coli</i>. This study presents the synthesis, characterization, and biological evaluation of the newly designed synthetic peptide AMPEC4, inspired by cytotoxin 5 from <i>Naja ashei</i> snake venom. AMPEC4 demonstrated potent antimicrobial properties with MIC values of 100 and 200 µg/mL, effectively inhibiting biofilm formation (up to 84%) and eradicating the pre-formed biofilm by up to 35%. The antibacterial activity of AMPEC4 was further supported by a membrane permeabilization assay, demonstrating its capacity to disrupt bacterial membrane integrity in a dose-dependent manner. Furthermore, AMPEC4 significantly promoted fibroblast migration, a critical step in tissue regeneration, while exhibiting notable biocompatibility, as evidenced by the absence of hemolytic, cytotoxic, and genotoxic effects. By addressing both infection control and tissue regeneration, AMPEC4 represents a promising therapeutic strategy for managing chronic wounds, particularly in the challenging environment of the anorectal region. Its ability to target <i>Escherichia coli</i> reference and clinical strains while accelerating the wound-healing process underscores its potential for future clinical applications.
ISSN:1420-3049